References
- Drummer O. H., Kourtis S. Biotransformation studies of di-acid angiotensin converting enzyme inhibitors. Arzneimittel-Forschung/Drug Research 1987; 37: 1225–1228
- Drummer O. H., Rowley K., Johnson H., Worland P., Workman B., Harris Q. L. G., Conway E. L., Louis W. J. Metabolism and pharmacodynamics of angiotensin converting enzyme with special reference to perindopril. Excerpta Medica 1987; 750: 545–550
- Drummer O. H., Kourtis S., Iakovidis D. Biotransformation studies of di-acid angiotensin converting enzyme inhibitors. Arzneimittel-Forschung/Drug Research 1988; 38: 647–650
- Eckert H. G., Badian M. J., Gantz D., Kellner H. M., Volz M. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-2-alanyl]-(1S, 3S, 5S)-2 aziobicycle [3.3.0] octane-3-carboxylic acid (HOe 498) in rat, dog and man. Arzneimittel-Forschung/Drug Research 1984; 34: 1435–1446
- Fournel-Gigleux S., Magdalou J., Laraurie C., Grislain L., Garnier M. H., Dabe J. F., Luijten W., Bromet N., Devissaguet M. Glucuronidation of perindopril by hepatic microsomes: interspecies comparison. Cellular and Molecular Aspects of Glucuronidation, G. Siest, J. Magdalou, B. Burchell. INSERM: Libbey Eurotext Ltd. 1988; Vol. 173: 305–309
- Tocco D. J., Deluna F. A., Duncan A. E. W., Vassil T. C., Ulm E. H. The physiological disposition and metabolism of elanapril maleate in laboratory animals. Drug Metabolism and Disposition 1982; 10: 15–19
- Vincent M., Remond G., Portein B., Serkiz B., Laubie M. Stereoselective synthesis of a new perhydroindole derivative of chiral imunodiacid, a potent inhibitor of angiotensin converting enzyme. Tetrahedron Letters 1982; 23: 1677–1680